259 related articles for article (PubMed ID: 17964138)
21. Role of nuclear progesterone receptor isoforms in uterine pathophysiology.
Patel B; Elguero S; Thakore S; Dahoud W; Bedaiwy M; Mesiano S
Hum Reprod Update; 2015; 21(2):155-73. PubMed ID: 25406186
[TBL] [Abstract][Full Text] [Related]
22. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
23. Cross-talk between growth factor and progesterone receptor signaling pathways: implications for breast cancer cell growth.
Pierson-Mullany LK; Skildum A; Faivre E; Lange CA
Breast Dis; 2003; 18():21-31. PubMed ID: 15687686
[TBL] [Abstract][Full Text] [Related]
24. Signaling inputs to progesterone receptor gene regulation and promoter selectivity.
Daniel AR; Knutson TP; Lange CA
Mol Cell Endocrinol; 2009 Sep; 308(1-2):47-52. PubMed ID: 19549591
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
26. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression.
Boonyaratanakornkit V; Bi Y; Rudd M; Edwards DP
Steroids; 2008 Oct; 73(9-10):922-8. PubMed ID: 18321550
[TBL] [Abstract][Full Text] [Related]
27. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
28. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors.
Qiu M; Olsen A; Faivre E; Horwitz KB; Lange CA
Mol Endocrinol; 2003 Apr; 17(4):628-42. PubMed ID: 12554776
[TBL] [Abstract][Full Text] [Related]
29. MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association.
Qiu M; Lange CA
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):147-57. PubMed ID: 12943699
[TBL] [Abstract][Full Text] [Related]
30. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
31. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle.
Boonyaratanakornkit V; McGowan E; Sherman L; Mancini MA; Cheskis BJ; Edwards DP
Mol Endocrinol; 2007 Feb; 21(2):359-75. PubMed ID: 17138644
[TBL] [Abstract][Full Text] [Related]
32. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
33. Regulation of gene expression by progesterone in cancer cells: effects on cyclin D1, EGFR and VEGF.
Hernández-Hernández OT; Camacho-Arroyo I
Mini Rev Med Chem; 2013 Apr; 13(5):635-42. PubMed ID: 23432380
[TBL] [Abstract][Full Text] [Related]
34. Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.
Leehy KA; Truong TH; Mauro LJ; Lange CA
J Steroid Biochem Mol Biol; 2018 Feb; 176():88-93. PubMed ID: 28442393
[TBL] [Abstract][Full Text] [Related]
35. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
36. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
Zhang X; Jeyakumar M; Bagchi MK
J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.
Pierson-Mullany LK; Lange CA
Mol Cell Biol; 2004 Dec; 24(24):10542-57. PubMed ID: 15572662
[TBL] [Abstract][Full Text] [Related]
38. Progestin receptor subtypes in the brain: the known and the unknown.
Mani S
Endocrinology; 2008 Jun; 149(6):2750-6. PubMed ID: 18308838
[TBL] [Abstract][Full Text] [Related]
39. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term.
Karteris E; Zervou S; Pang Y; Dong J; Hillhouse EW; Randeva HS; Thomas P
Mol Endocrinol; 2006 Jul; 20(7):1519-34. PubMed ID: 16484338
[TBL] [Abstract][Full Text] [Related]
40. Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.
Moore NL; Narayanan R; Weigel NL
Steroids; 2007 Feb; 72(2):202-9. PubMed ID: 17207508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
